前列腺癌的核医学成像在过去十年中取得了显着进展。本评论提出了一项调查。 PSMA-PET/CT 是一种已推出的高精度新方法，但骨扫描和骨 PET 仍在继续广泛应用。 PSMA-PET/CT 仍然缺乏足够的患者结果数据，无法在用于初步分期时推荐治疗分配。然而，文献和临床指南支持其在生化复发阶段的使用。在丹麦，使用核医学检查治疗前列腺癌符合临床指南建议。以开放获取 CC-BY-NC-BD 4.0 形式发布。 https://creativecommons.org/licenses/by-nc-nd/4.0/。

Nuclear medicine imaging for prostate cancer has advanced significantly over the past decade. A survey is presented in this review. PSMA-PET/CT is a new highly accurate method that has been introduced, but bone scans and bone-PET continue to be widely applied. PSMA-PET/CT still lacks sufficient patient outcome data to be recommended for treatment allocation when used for primary staging. However, the literature and clinical guidelines support its use at the stage of biochemical recurrence. In Denmark, the use of nuclear medicine examinations for prostate cancer aligns with clinical guideline recommendations.Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.